{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:26:33Z","timestamp":1793456793474,"version":"4.5.0"},"reference-count":33,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA-POR-2015-1099"],"award-info":[{"award-number":["HRA-POR-2015-1099"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["ILP-POR-2017-024"],"award-info":[{"award-number":["ILP-POR-2017-024"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/FRL\/3845"],"award-info":[{"award-number":["16\/FRL\/3845"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mesenchymal stromal cells (MSCs) have a multimodal, immunomodulatory mechanism of action and are now in clinical trials for single organ and systemic sepsis. However, a number of practicalities around source, homogeneity and therapeutic window remain to be determined. Here, we utilised conditioned medium from CD362+-sorted umbilical cord-human MSCs (UC-hMSCs) for a series of in vitro anti-inflammatory assays and the cryopreserved MSCs themselves in a severe (Series 1) or moderate (Series 2+3) caecal ligation and puncture (CLP) rodent model. Surviving animals were assessed at 48 h post injury induction. MSCs improved human lung, colonic and kidney epithelial cell survival following cytokine activation. In severe systemic sepsis, MSCs administered at 30 min enhanced survival (Series 1), and reduced organ bacterial load. In moderate systemic sepsis (Series 2), MSCs were ineffective when delivered immediately or 24 h later. Of importance, MSCs delivered 4 h post induction of moderate sepsis (Series 3) were effective, improving serum lactate, enhancing bacterial clearance from tissues, reducing pro-inflammatory cytokine concentrations and increasing antimicrobial peptides in serum. While demonstrating benefit and immunomodulation in systemic sepsis, therapeutic efficacy may be limited to a specific point of disease onset, and repeat dosing, MSC enhancement or other contingencies may be necessary.<\/jats:p>","DOI":"10.3390\/ijms21218270","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T10:29:00Z","timestamp":1604485740000},"page":"8270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Umbilical Cord-Derived CD362+ Mesenchymal Stromal Cells Attenuate Polymicrobial Sepsis Induced by Caecal Ligation and Puncture"],"prefix":"10.3390","volume":"21","author":[{"given":"Hector","family":"Gonzalez","sequence":"first","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Keane","sequence":"additional","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H.","family":"Masterson","sequence":"additional","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahd","family":"Horie","sequence":"additional","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Elliman","sequence":"additional","affiliation":[{"name":"Orbsen Therapeutics Ltd., Galway H91 DET7, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan D.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Physiology, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scully","sequence":"additional","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1246-9573","authenticated-orcid":false,"given":"John G.","family":"Laffey","sequence":"additional","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Anaesthesia, School of Medicine, National University of Ireland, Galway H91 TK33, Ireland"},{"name":"Regenerative Medicine Institute, National University of Ireland, Galway H91 TK33, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"i1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: Pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/jcp.25028","article-title":"The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis","volume":"230","author":"Ho","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.21037\/jtd.2018.08.28","article-title":"Cell therapy in acute respiratory distress syndrome","volume":"10","author":"Horie","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rezoagli, E., Murphy, E.J., Laffey, J., and O\u2019Toole, D. (2019). The Safety and Efficiency of Addressing ARDS Using Stem Cell Therapies in Clinical Trials. Stem Cell-Based Ther. Lung Dis., 219\u2013238.","DOI":"10.1007\/978-3-030-29403-8_12"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00109-009-0523-7","article-title":"Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands","volume":"88","author":"Nemeth","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/thoraxjnl-2015-206813","article-title":"Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat","volume":"70","author":"Devaney","year":"2015","journal-title":"Thorax"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40635-015-0065-y","article-title":"Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury","volume":"3","author":"Hayes","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.4161\/cc.6.23.5095","article-title":"Biochemical heterogeneity of mesenchymal stem cell populations: Clues to their therapeutic efficacy","volume":"6","author":"Phinney","year":"2007","journal-title":"Cell Cycle"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ALN.0000000000002327","article-title":"Syndecan-2-positive, Bone Marrow-derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats","volume":"129","author":"Masterson","year":"2018","journal-title":"Anesthesiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13287-020-01624-8","article-title":"Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy","volume":"11","author":"Horie","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0000000000000545","article-title":"Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat","volume":"122","author":"Hayes","year":"2015","journal-title":"Anesthesiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jamp.2019.1542","article-title":"Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates","volume":"33","author":"McCarthy","year":"2020","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-9343(97)00136-8","article-title":"Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony-stimulating factor","volume":"103","author":"Francois","year":"1997","journal-title":"Am. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41423-018-0164-2","article-title":"High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: A prospective cohort study","volume":"16","author":"Huang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.shk.0000190827.36406.6e","article-title":"Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability","volume":"24","author":"Pickkers","year":"2005","journal-title":"Shock"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Whitney, J.E., Silverman, M., Norton, J.S., Bachur, R.G., and Melendez, E. (2018). Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children with Severe Sepsis and Septic Shock. Pediatr. Emerg. Care.","DOI":"10.1097\/PEC.0000000000001638"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1152\/ajpregu.00098.2018","article-title":"Wharton\u2019s jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation","volume":"318","author":"Capcha","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3537609","DOI":"10.1155\/2018\/3537609","article-title":"A Novel Mechanism of Mesenchymal Stromal Cell-Mediated Protection against Sepsis: Restricting Inflammasome Activation in Macrophages by Increasing Mitophagy and Decreasing Mitochondrial ROS","volume":"2018","author":"Li","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13287-019-1352-4","article-title":"Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10","volume":"10","author":"Park","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13287-017-0734-8","article-title":"Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway","volume":"8","author":"Pedrazza","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/viru.26516","article-title":"The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?","volume":"5","author":"Boomer","year":"2014","journal-title":"Virulence"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Venet, F., Demaret, J., Gossez, M., and Monneret, G. (2020). Myeloid cells in sepsis-acquired immunodeficiency. Ann. N. Y. Acad. Sci.","DOI":"10.1111\/nyas.14333"},{"key":"ref_29","first-page":"409","article-title":"Sepsis: Diagnosis and Management","volume":"101","author":"Gauer","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1099\/jmm.0.000861","article-title":"Human adipose tissue-derived mesenchymal stem\/stromal cells adhere to and inhibit the growth of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"67","author":"Wood","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref_32","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/cid\/cir692","article-title":"Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections","volume":"53","author":"Rampini","year":"2011","journal-title":"Clin. Infect. Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/8270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:18Z","timestamp":1760178558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/8270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":33,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["ijms21218270"],"URL":"https:\/\/doi.org\/10.3390\/ijms21218270","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}